| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/18/2006 | US7030152 Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 04/18/2006 | US7030109 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7029869 Feeding assay for identifying nematicidal compounds |
| 04/18/2006 | US7029859 Sequences for targeting metastatic cells |
| 04/18/2006 | US7029655 Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits |
| 04/18/2006 | US7029654 anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 04/18/2006 | US7029653 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 04/13/2006 | WO2006039678A2 Establishment of highly metastatic cell lines using nog mice |
| 04/13/2006 | WO2006038185A2 Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy |
| 04/13/2006 | WO2006038184A2 Compounds, kits and methods for use in medical imaging |
| 04/13/2006 | WO2006037882A1 Use of vcam-1 ligands for detecting and/or treating cardiovascular diseases |
| 04/13/2006 | WO2006037803A1 Contrast agent formulations for the visualization of the lymphatic system |
| 04/13/2006 | WO2006037625A2 Non-invasive method for assessing gastric motility |
| 04/13/2006 | WO2006014381A9 Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies |
| 04/13/2006 | WO2006011810A3 Mr imaging method for the discrimination between healthy and tumour tissue |
| 04/13/2006 | WO2005117998A3 Smvt transporters expressed in cancer cells |
| 04/13/2006 | WO2005113020A3 Skin test using partially-hydrolysed allergenic proteins |
| 04/13/2006 | WO2005110496A3 Biomolecular contrast agents for therapy optimization in radiation therapy with proton or ion beams |
| 04/13/2006 | US20060079806 Method and apparatus for measuring factors in mammary fluids |
| 04/13/2006 | US20060079770 Biopsy site marker |
| 04/13/2006 | US20060078967 Antibodies for IL-17 receptor like polypeptides and uses thereof |
| 04/13/2006 | US20060078966 IL-17 receptor like polypeptides and uses thereof |
| 04/13/2006 | US20060078933 Identifying a modulator of IL-17 receptor-like polypeptide activity; drug screening; treating inflammation |
| 04/13/2006 | US20060078503 1,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them |
| 04/13/2006 | US20060078502 Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents |
| 04/13/2006 | US20060078501 High frequency ultrasound imaging using contrast agents |
| 04/13/2006 | US20060078500 Hyaluronic acid bound to a bead support by a chelator that is a polyamino-polycarboxylic acid such as 1,4,7,10-tetraazacyclodo-decane-N,N',N'', N'''-tetraacetic acid or ethylenedicysteine; cancer diagnosis |
| 04/13/2006 | US20060078499 Use of hedgehog agonist to treat depression |
| 04/13/2006 | US20060078498 Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192 |
| 04/13/2006 | US20060078497 Health management and monitoring with and without weight loss |
| 04/13/2006 | DE10311628B4 Bildgebungsverfahren Imaging methods |
| 04/13/2006 | DE102004049479A1 Proteinkonjugate zur Verwendung in Therapie, Diagnose und Chromatographie Protein conjugates for use in therapy, diagnosis and chromatography |
| 04/13/2006 | CA2582022A1 Methods for the administration of iloperidone |
| 04/12/2006 | EP1645634A2 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/12/2006 | EP1644941A1 Magnetic nanoparticles having improved magnetic properties |
| 04/12/2006 | EP1644732A2 Animal model for the analysis of tumor metastasis |
| 04/12/2006 | EP1644728A2 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy |
| 04/12/2006 | EP1644330A2 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 04/12/2006 | EP1643958A2 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 04/12/2006 | EP1423436B1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 04/12/2006 | EP1372553A4 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 04/12/2006 | EP0793718B1 Molecular tagging system |
| 04/12/2006 | CN1250571C Specific binding molecules for scintigraphy, conjugates containing them and uses |
| 04/12/2006 | CN1250294C Photosensitive and method for production thereof |
| 04/12/2006 | CN1250279C Liposome targeting of matrix metalloproteinase inhibitors |
| 04/11/2006 | US7025949 In-vivo diagnostic method by means of near infrared radiation |
| 04/11/2006 | CA2229470C Process for the purification of an intermediate in the preparation of iopamidol |
| 04/06/2006 | WO2006037124A2 Container with constrained quality maintenance agent |
| 04/06/2006 | WO2006036777A2 Diagnosis of diseases associated with cox-2 expression |
| 04/06/2006 | WO2006036071A2 Urokinase plasminogen activator receptor targeted contrast agent |
| 04/06/2006 | WO2006035678A1 Diagnostic agent for tumor |
| 04/06/2006 | WO2006035444A2 Composition for improving efficiency of drug delivery |
| 04/06/2006 | WO2005024442A3 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
| 04/06/2006 | US20060074062 Substituted porphyrins |
| 04/06/2006 | US20060073333 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 04/06/2006 | US20060073175 Methods and formulations for delivery of pharmacologically active agents |
| 04/06/2006 | US20060073140 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073101 Method for convection enhanced delivery of therapeutic agents |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | US20060073099 Treatment screening methods |
| 04/06/2006 | US20060073098 Irrigating solution for neurosurgical procedures |
| 04/06/2006 | US20060073097 Determination of insulin sensitivity, insulin resistance, and non-insulin dependent Diabetes mellitus based on oral glucose tolerance test data and lipid ratios from reference populations that define an insulin resistance index |
| 04/06/2006 | DE102004048265A1 Expandable and contractable device comprises expandable and contractable base containing a substance, which excites due to radiation and a presentation of the base in in vivo events is obtained by picture forming procedures |
| 04/06/2006 | DE102004045748A1 Stöchiometrisch definierte farbstoffmarkierte Substanzen zur Messung der glomerulären Filtrationsrate, ihre Herstellung und Verwendung Stoichiometrically defined dye-labeled substances for measuring the glomerular filtration rate, their preparation and use |
| 04/06/2006 | CA2581204A1 Aminolevulinic acid compounds for diagnosing tumors |
| 04/06/2006 | CA2580464A1 Urokinase plasminogen activator receptor targeted contrast agent |
| 04/05/2006 | EP1642597A2 Method of measuring physiological function |
| 04/05/2006 | EP1641806A2 Glycerophosphocholine and its derivatives for medical imaging of neuropsychiatric disorders |
| 04/05/2006 | EP1641522A2 Gastrointestinal methods and apparatus for use in treating disorders |
| 04/05/2006 | EP1641495A2 Optically pure and enriched isomers of chelating ligands and contrast agents |
| 04/05/2006 | EP1641492A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 04/05/2006 | EP1049718B1 Use of the antibody 271.14d9.f8 (dsm acc2331) to inhibit in vitro alphavbeta6-integrin attachment to fibronectin |
| 04/05/2006 | CN1756957A Method of detecting onset risk of encephalitis or encephalopathy |
| 04/05/2006 | CN1756846A Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 04/05/2006 | CN1756557A Sincalide formulations |
| 04/05/2006 | CN1754577A Contrast agent |
| 04/05/2006 | CN1249070C Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same |
| 04/05/2006 | CN1249058C Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| 04/04/2006 | US7022318 Kit of parts for treating urinary incontinence in mammals |
| 04/04/2006 | US7022309 Targeting molecule linked to an imaging agent |
| 04/04/2006 | CA2327393C Solution for the preparation of a pharmaceutical substance for diagnosing and/or treating tissue pathologies |
| 03/30/2006 | WO2006034005A2 Imaging reporters of transgene expression |
| 03/30/2006 | WO2006033701A2 Reagent sets and gene signatures for renal tubule injury |
| 03/30/2006 | WO2006032911A2 Metalloproteinase inhibitor imaging agents |
| 03/30/2006 | WO2006032705A2 Contrast agents encapsulating systems for cest imaging |
| 03/30/2006 | WO2006032704A2 Diagnostic compounds for targeting a chemokine receptor |
| 03/30/2006 | WO2006032441A2 Stoichiometrically defined dye-labeled substances for measuring glomerular filtration rate |
| 03/30/2006 | WO2005115135A9 Mouse model of crohn’s disease and a method to develop specific therapeutics |
| 03/30/2006 | WO2005105838A3 Ion channel |
| 03/30/2006 | WO2005070471A3 Articles comprising magnetic material and bioactive agents |
| 03/30/2006 | WO2005046573A3 Pro104 antibody compositions and methods of use |
| 03/30/2006 | WO2005032512A3 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067890 Telomelysin/GFP-expressing recombinant virus |
| 03/30/2006 | US20060067889 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents |
| 03/30/2006 | US20060067888 detecting a M. tuberculosis Apa protein-specific CD4+ T lymphocyte response; detected CD4+ T lymphocyte response is indicative of tuberculosis in said patient and differentiates tuberculosis from an immunization with BCG (Bacillus Calmette-Guerin) |
| 03/30/2006 | US20060067887 Scoring estrogen and progesterone receptors expression based on image analysis |